-
In this issue: Aspirin use and AMD risk; using NSAIDs and antihypertensive agents; and FDA actions.
-
Do the presence or absence of acetylcholine receptor (AchR)-binding antibodies (Abs) and muscle-specific kinase (MuSK) Abs correlate with disease phenotype in myasthenia gravis (MG)?
-
Chesnut et al have performed the first randomized, controlled trial to evaluate the benefit of intracranial pressure (ICP) monitoring on outcome after severe traumatic brain injury (TBI).
-
-
Although many children with a first febrile seizure will have had a simple febrile seizure, a relatively common and benign childhood illness, a subset will present in febrile status epilepticus, the most severe in the spectrum of febrile seizures.
-
In this issue: Apixaban approval; new dental clinical practice guideline; apixaban for VTE; aspirin resistance; tamoxifen treatment; and FDA actions.
-
Based on the prior work of patrick kwan and martin brodie, The efectiveness of the first antiepileptic drug (AED) in new-onset epilepsy is nearly 50%.
-
Dr. Henchcliffe reports she is on the speakers bureau and advisory board for Allergan and Teva; speakers bureau for Boehringer-Ingelheim, GlaxoSmith-Kline, and Novartis; advisory board for Merz; and is a consultant for Gerson Lehman Group and Guidepoint Global.
-
Treatment and Outcome after Acute Cervical Artery Occlusion with Stroke; Continuous Transcranial Doppler Insonation Can Determine Recanalization Following Acute Ischemic Stroke; Antithrombotic Therapy Appears to be Safe for Patients with Cerebral Cavernous Malformations
-
Zolpidem and risk of falls; AVR and anticoagulation; statins in cancer patients; and FDA actions.
